PLEKHM3 Activators
PLEKHM3 activators encompass a range of chemical compounds that indirectly bolster the functional activity of PLEKHM3 through distinct signaling pathways. Forskolin and 8-Br-cAMP are quintessential in raising the levels of cAMP, which is a pivotal second messenger in cellular signaling, thereby enhancing PLEKHM3 activity through cAMP-dependent protein kinase A (PKA). This kinase phosphorylates various substrates, potentially affecting trafficking pathways where PLEKHM3 is implicated. Ionomycin and A23187 act as calcium ionophores, raising intracellular calcium levels and activating calcium-sensitive signaling mechanisms; this elevation in calcium is a signal that can indirectly augment PLEKHM3's role in autophagy and endo-lysosomal trafficking. PMA, by activating protein kinase C (PKC), and Sphingosine-1-phosphate, through receptor-mediated signaling, modulate different facets of cellular signaling that converge on pathways involving PLEKHM3, particularly influencing vesicle formation and trafficking.
Further, inhibitors like LY294002, U0126, and SB203580, which target PI3K, MEK, and p38 MAPK respectively, can create a signaling environment conducive to the enhancement of PLEKHM3's function by shifting the balance of intracellular pathways. This shift can lead to anincrease in the activity of pathways that PLEKHM3 is involved in, such as autophagy and membrane trafficking. ETYA, as an inhibitor of lipoxygenases, may favor PLEKHM3 activity by reducing competitive inflammatory signaling pathways, thereby indirectly promoting PLEKHM3 related functions. NSC 23766, which impedes Rac1, has the potential to enhance PLEKHM3 by modifying cytoskeletal dynamics, crucial for membrane trafficking, and vesicle transport. Lastly, EGCG, through its broad inhibition of protein kinases, may bolster PLEKHM3 activity by influencing signaling pathways that regulate vesicle formation, transport, and autophagy. Collectively, these activators, through their targeted modulation of cellular signaling, facilitate the enhancement of PLEKHM3-mediated functions without the need for upregulating its expression or direct activation, underscoring their role in fine-tuning the cellular processes that PLEKHM3 is integral to.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent protein kinase C (PKC) activator. PKC activation can lead to the phosphorylation of various proteins involved in vesicular transport and membrane dynamics. PLEKHM3 interacts with Rab7 in endosomal transport; PKC-mediated phosphorylation events can enhance PLEKHM3-mediated vesicle trafficking by modifying its interaction with Rab7. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent proteins. As PLEKHM3 is involved in vesicular transport processes, the elevation of calcium concentration could enhance the interaction of PLEKHM3 with its associated proteins, such as Rab7, thereby facilitating its role in vesicle trafficking. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA. This activation can result in enhanced phosphorylation of proteins involved in vesicular transport. By promoting the phosphorylation of proteins in the PLEKHM3 pathway, 8-Br-cAMP can indirectly increase PLEKHM3-mediated endosomal transport and positioning, augmenting its functional activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, involved in intracellular signaling and vesicle formation. S1P signaling can modulate the endocytic pathway where PLEKHM3 functions. By altering the endocytic pathway dynamics, S1P can indirectly enhance the role of PLEKHM3 in autophagosome-lysosome fusion processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known inhibitor of several kinases. By inhibiting competitive kinase pathways, EGCG could shift the signaling equilibrium to favor pathways where PLEKHM3 is active, potentially enhancing its role in vesicular transport pathways, particularly in regards to autophagosome maturation and endosome-lysosome interactions. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is a cofactor for sirtuins, which are involved in deacetylation of proteins. Sirtuin activity can modulate autophagy through deacetylation of autophagy-related proteins. Since PLEKHM3 is involved in autophagosome maturation, the activation of sirtuins by NAD+ may enhance the function of PLEKHM3 in these processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/AKT/mTOR signaling pathway. This pathway plays a role in autophagy regulation. By inhibiting PI3K, LY294002 could indirectly activate autophagy, thereby potentially enhancing the role of PLEKHM3 in autophagosome maturation and subsequent fusion with lysosomes. | ||||||